MOTS-c Peptide: Latest Research Data & Industry Outlook
Executive Summary
Abstract: MOTS-c, a mitochondrial-derived peptide, regulates metabolism and aging. Latest research highlights its role in insulin sensitivity and exercise mimetics. Industry outlook is positive, driven by anti-aging demand. Compared to other peptides, MOTS-c shows unique mitochondrial targeting. Selection criteria include purity, source, and stability. Key knowledge: dosage and cycling protocols.
Target Keyword: mots c peptide
Core Molecular Specs & Technical Index
MOTS-c peptide is a mitochondrial-derived peptide encoded within the mitochondrial genome, specifically the 12S rRNA region. It consists of 16 amino acids with the sequence MRWQEMGYIFYPRKLR. This peptide is primarily recognized for its role in regulating metabolic homeostasis, enhancing insulin sensitivity, and promoting cellular adaptation to stress. The target buyer group includes research laboratories, cosmetic ingredient formulators, and bulk peptide distributors seeking high-purity bioactive compounds for anti-aging and metabolic studies. The core value of MOTS-c lies in its unique mitochondrial targeting mechanism, which distinguishes it from nuclear-encoded peptides and offers novel pathways for modulating energy metabolism and longevity.
- Molecular Weight: Approximately 2,174.5 Da, ensuring optimal bioavailability and receptor interaction.
- Purity Standard: ≥98% as verified by HPLC analysis, with endotoxin levels below 1 EU/mg for research-grade applications.
- Solubility: Readily soluble in sterile water or PBS at 1 mg/mL, with recommended reconstitution in acetic acid for enhanced stability.
- Storage Conditions: Lyophilized powder stable for 24 months at -20°C; reconstituted solution must be used within 30 days at 4°C.
- Sequence Integrity: Confirmed via mass spectrometry and amino acid analysis, ensuring batch-to-batch consistency.
Industry data indicates that the global peptide therapeutics market is projected to reach USD 50.6 billion by 2030, with mitochondrial-derived peptides like MOTS-c representing a rapidly growing segment due to their dual role in metabolic regulation and anti-aging research.
Manufacturing & Quality Control
The production of MOTS-c peptide follows a rigorous solid-phase peptide synthesis (SPPS) process using Fmoc chemistry. This method ensures high coupling efficiency and minimal side reactions. After synthesis, the crude peptide is cleaved from the resin and purified via preparative reverse-phase HPLC to achieve the required purity. Quality control includes multiple analytical checks to guarantee product integrity and safety.
- Production Process: Automated SPPS with real-time monitoring of coupling cycles to optimize yield.
- Purification: Two-step HPLC purification using C18 columns, followed by lyophilization to obtain a white powder.
- Third-Party Testing: Independent labs verify purity, endotoxin levels, and bioactivity through cell-based assays.
- Certification: Each batch includes a Certificate of Analysis (CoA) with HPLC, MS, and solubility data.
- Stability Studies: Accelerated stability testing at 40°C/75% RH for 6 months confirms shelf-life claims.
Commercial Application Scenarios
MOTS-c peptide is utilized across multiple B2B sectors, including cosmetic formulation, laboratory research, and bulk distribution. In cosmetic formulations, it is incorporated into anti-aging serums and creams at concentrations of 0.1–0.5% to support skin metabolism and mitochondrial health. For lab research, it serves as a tool compound in studies on insulin signaling, exercise mimetics, and mitochondrial biogenesis. Bulk wholesale buyers often source MOTS-c for preclinical trials or as a raw material for custom peptide libraries.
- Cosmetic Formulation: Added to topical products targeting skin aging, with stability enhanced by encapsulation in liposomes.
- Lab Research: Used in cell culture and animal models to investigate metabolic pathways and age-related decline.
- Bulk Wholesale: Supplied in gram quantities for pharmaceutical R&D, with custom packaging options for GMP compliance.
mots-c peptide VS Ordinary Low-Grade Peptides
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 70–85% by HPLC | Higher purity reduces batch variability and improves research reproducibility. |
| Source | GMP-certified facility | Non-certified labs | Ensures traceability and compliance with international standards. |
| Stability | 24 months at -20°C | 6–12 months at -20°C | Extended shelf life lowers inventory risk for bulk buyers. |
| Bioactivity | Verified via cell-based assays | Not tested | Guarantees functional performance in metabolic studies. |
Bulk Purchase Selection Guide
When sourcing MOTS-c peptide in bulk, buyers must avoid common pitfalls such as low purity, mislabeled sequences, and inadequate documentation. Selection standards include verifying the supplier’s manufacturing certifications, requesting a CoA for each batch, and confirming the peptide’s solubility profile. A buyer checklist should cover purity analysis, endotoxin testing, and stability data to ensure the product meets research or formulation requirements.
- Common Pitfalls: Purchasing from suppliers without HPLC data or with vague purity claims.
- Selection Standards: Require ≥98% purity, endotoxin <1 EU/mg, and mass spectrometry confirmation.
- Buyer Checklist: Request CoA, third-party test results, and storage guidelines before ordering.
Core Product Advantages
Our MOTS-c peptide offers distinct advantages in purity, stability, and cost performance. With ≥98% purity verified by HPLC, it ensures minimal interference in sensitive assays. The lyophilized form remains stable for 24 months under proper storage, reducing waste for bulk buyers. Competitive pricing combined with technical support from peptide synthesis experts makes it a preferred choice for laboratories and formulators seeking reliable raw materials.
- Purity: Consistently ≥98% with batch-to-batch reproducibility.
- Stability: Extended shelf life with no degradation under recommended conditions.
- Cost Performance: Bulk discounts available without compromising quality.
- Technical Support: Access to application notes and protocol optimization guidance.
Frequently Asked Questions
Q: What is the recommended dosage and cycling protocol for MOTS-c in research settings?
A: In animal studies, typical dosages range from 0.5 to 5 mg/kg body weight administered intraperitoneally, with cycling protocols involving 5 days on and 2 days off to mimic physiological rhythms. For cell culture, concentrations of 10–100 µM are common, with exposure times of 24–48 hours.
Q: How does MOTS-c compare to other mitochondrial peptides like humanin?
A: While both are mitochondrial-derived, MOTS-c uniquely targets the AMPK pathway to enhance insulin sensitivity and exercise mimetic effects, whereas humanin primarily interacts with IGF-1 signaling. This makes MOTS-c more suitable for metabolic and aging studies.
Q: What are the key selection criteria for choosing a MOTS-c supplier?
A: Key criteria include verified purity ≥98%, third-party HPLC and MS data, endotoxin testing, and a documented manufacturing process. Additionally, suppliers should provide stability data and offer custom packaging for bulk orders.